Omega-3 fatty acid supplementation

Human RCT evidence exists but is genuinely contested, and none of it measures lifespan or healthspan. VITAL randomised over 25,000 adults to 1 g/day marine n-3 and found no reduction in major cardiovascular events (HR 0.92) and no reduction in cancer (HR 1.03); the authors concluded supplementation did not lower incidence of either. STRENGTH, in 13,000+ statin-treated high-risk patients with high triglycerides and low HDL, found no difference versus corn oil (12.0% vs 12.2%, HR 0.99). REDUCE-IT is the main positive trial, but it tested prescription icosapent ethyl (high-dose purified EPA), not ordinary fish oil, in statin-treated patients with elevated triglycerides, cutting the primary endpoint from 22.0% to 17.2% (HR 0.75); its mineral-oil comparator remains debated. So: for a general, well-nourished population taking over-the-counter fish oil, the best evidence is null. For a specific high-risk, high-triglyceride, statin-treated subgroup, a specific prescription drug showed benefit. What is NOT shown: any effect on mortality-as-longevity, biological ageing markers, or healthspan endpoints. Observational associations between higher blood omega-3 and life expectancy (cited by Everlab) are not causal and should not be presented as trial evidence. Two caveats on this profile: the TGA website was unreachable across repeated fetch attempts this session, so the Australian regulatory field is returned null rather than guessed; and Melbourne Functional Medicine's blog returned HTTP 403, so its omega-3 recommendation could not be verified and it is excluded from the clinic list. Advantage Medical Group (Singapore) does recommend omega-3s on its own site, but it is not in the supplied SG clinic universe, so it is likewise excluded from offeredBy.

What it is

Plain-language explainer

Categories

Common questions

What is Omega-3 fatty acid supplementation?

Human RCT evidence exists but is genuinely contested, and none of it measures lifespan or healthspan. VITAL randomised over 25,000 adults to 1 g/day marine n-3 and found no reduction in major cardiovascular events (HR 0.92) and no reduction in cancer (HR 1.03); the authors concluded supplementation did not lower incidence of either. STRENGTH, in 13,000+ statin-treated high-risk patients with high triglycerides and low HDL, found no difference versus corn oil (12.0% vs 12.2%, HR 0.99). REDUCE-IT is the main positive trial, but it tested prescription icosapent ethyl (high-dose purified EPA), not ordinary fish oil, in statin-treated patients with elevated triglycerides, cutting the primary endpoint from 22.0% to 17.2% (HR 0.75); its mineral-oil comparator remains debated. So: for a general, well-nourished population taking over-the-counter fish oil, the best evidence is null. For a specific high-risk, high-triglyceride, statin-treated subgroup, a specific prescription drug showed benefit. What is NOT shown: any effect on mortality-as-longevity, biological ageing markers, or healthspan endpoints. Observational associations between higher blood omega-3 and life expectancy (cited by Everlab) are not causal and should not be presented as trial evidence. Two caveats on this profile: the TGA website was unreachable across repeated fetch attempts this session, so the Australian regulatory field is returned null rather than guessed; and Melbourne Functional Medicine's blog returned HTTP 403, so its omega-3 recommendation could not be verified and it is excluded from the clinic list. Advantage Medical Group (Singapore) does recommend omega-3s on its own site, but it is not in the supplied SG clinic universe, so it is likewise excluded from offeredBy.

How strong is the evidence for Omega-3 fatty acid supplementation?

Clinical. There is human trial evidence, which is the strongest grade variis applies to a protocol.

Is Omega-3 fatty acid supplementation approved in Singapore?

Health Sciences Authority position on record: Not a registered therapeutic product. Fish oil / omega-3 is regulated by HSA as a health supplement, which requires no pre-market approval or licensing; dealers self-assess compliance with HSA safety, quality and labelling requirements and may notify HSA voluntarily. Legally sold and freely available, but it may not be labelled, advertised or promoted for any specific medicinal purpose, or claimed to treat or prevent disease.. An evidence grade and a regulatory approval are different questions.

Is Omega-3 fatty acid supplementation approved in Australia?

variis has no Therapeutic Goods Administration position on file for Omega-3 fatty acid supplementation. Absence of a recorded position is not approval.

Which clinics offer Omega-3 fatty acid supplementation?

1 clinic in the variis directory across Singapore and Australia has Omega-3 fatty acid supplementation on record. Each is listed on this page with its own sourced profile.

What else is Omega-3 fatty acid supplementation called?

Also known as Fish oil, EPA/DHA, Marine n-3 fatty acids, Omega-3 index, Icosapent ethyl (prescription EPA).